By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BrainStorm Cell Therapeutics Inc. 

Tel Aviv      Israel
Phone: n/a Fax:



Company News
BrainStorm Cell Announces Publication of NurOwn Autism Research Study 4/19/2017 7:27:44 AM
BrainStorm Cell Announces Financial Results For 2016 And Provides Business Update 3/30/2017 8:52:01 AM
BrainStorm Cell Strengthens Management Team With Appointment Of Ralph Z. Kern, MD, MHSc As Chief Operating Officer And Chief Medical Officer 3/6/2017 8:07:57 AM
BrainStorm Cell Announces MOU With Tel Aviv Sourasky Medical Center To Make NurOwn Available To Patients As A Hospital Exemption Product 3/1/2017 10:03:47 AM
BrainStorm Cell Names Dr. June S. Almenoff And Arturo O. Araya To Its Board Of Directors As Company Prepares For Clinical And Commercial Success 2/27/2017 8:16:06 AM
BrainStorm Cell Seeking Approval To Distribute NurOwn In Canada 2/21/2017 7:25:43 AM
City of Hope To Manufacture NurOwn For BrainStorm Cell's Phase III ALS Clinical Trial 2/16/2017 7:24:32 AM
BrainStorm Cell Announces Validation Of NurOwn Cryopreservation Process 1/30/2017 8:17:43 AM
BrainStorm Cell Reports On Successful End Of Phase 2 Meeting With FDA, Upcoming Phase 3 Trial And Planned Application For Hospital Exemption For NurOwn 12/19/2016 8:28:44 AM
BrainStorm Cell Release: In-Depth Analyses Presented At International Symposium On ALS/MND Suggest Strong Biological Effect For NurOwn; Evidence Of Halting Of Disease Progression 12/14/2016 6:55:48 AM